SEOUL, South Korea, Feb. 4, 2026 /PRNewswire/ — Yuyu Pharma announced today a strategic investment in James & Ella, the United Kingdom’s fastest-growing freeze-dried pet nutrition company. Founded by entrepreneur James Middleton, James & Ella has rapidly established itself as the leader of the UK freeze-dried category, with nationwide distribution through Sainsbury’s, Waitrose, Ocado, and Amazon UK, supported by a strongly expanding direct-to-consumer subscription channel.

This investment reflects Yuyu Pharma’s expanding global focus on premium pet wellness. Freeze-dried nutrition is one of the fastest-growing segments in the pet category, fueled by rising demand for human-grade ingredients, superior digestibility, and science-led product design. James & Ella is leading this movement, supported by advanced freeze-drying technology, strong retail performance, and a brand philosophy centered on health, trust, and emotional connection.

The partnership with James & Ella builds on Yuyu Pharma’s broader strategy in the animal-health sector. In the past two years, Yuyu has invested in VetmAb Bio, a developer of veterinary monoclonal antibodies; Dalan Animal Health, the pioneer of invertebrate vaccines; and DogPPL, a premium U.S. pet-wellness lifestyle company. These ventures together form a rapidly growing platform that spans biologics, aquaculture, pet nutrition, and consumer wellness.

"James & Ella is redefining the future of pet nutrition, and we see significant opportunity in their vision, technology, and category leadership," said Robert Wonsang Yu, CEO of Yuyu Pharma. "Our investment reflects our confidence in freeze-dried nutrition and in the long-term potential of James & Ella as a science-driven pet wellness brand."

About Yuyu PharmaFounded in 1941, Yuyu Pharma(KRX:000220) is a Korea-based healthcare company focused on pharmaceuticals, medical devices, and health supplements that improve quality of life. As part of its global growth strategy, the company invests in early-stage and high-growth innovators across biotechnology, sustainability, and animal health through Yuyu Venture Studio.

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

SERES Net Profit for First Three Quarters Hits 5.312 Billion RMB, to Be the First Luxury NEV Maker with "A+H" Listing

CHONGQING, China, Nov. 2, 2025 /PRNewswire/ — On October 30, SERES released its…

Wellness Culture Gains Momentum Across Asia Pacific as 4 in 5 Consumers Prioritize Holistic Health – Herbalife Survey

HONG KONG, July 29, 2026 /PRNewswire/ — Herbalife, a premier health and…

Bedsure Introduces the OLoop Cervical Pillow: Two Sides. One Perfect Night's Sleep.

An innovative dual-sided ergonomic cervical pillow designed to adapt to changing sleep…